Norinchukin Bank The Purchases 1,762 Shares of Cardinal Health, Inc. $CAH

Key Points

• Norinchukin Bank increased its stake in Cardinal Health by 15.7%, acquiring an additional 1,762 shares, bringing its total holdings to 12,973 shares valued at approximately $1.79 million.
• Cardinal Health recently reported earnings of $2.08 per share, exceeding analysts' estimates, while also posting revenues of $60.16 billion for the quarter.
• The company declared a quarterly dividend of $0.5107 per share, which will be paid on October 15, reflecting an annualized yield of 1.4% and a payout ratio of 31.63%.

Norinchukin Bank The raised its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 15.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,973 shares of the company's stock after acquiring an additional 1,762 shares during the quarter. Norinchukin Bank The's holdings in Cardinal Health were worth $1,787,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of CAH. First Trust Advisors LP boosted its position in Cardinal Health by 39.9% during the 4th quarter. First Trust Advisors LP now owns 222,764 shares of the company's stock valued at $26,346,000 after acquiring an additional 63,535 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Cardinal Health by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,238,848 shares of the company's stock valued at $146,517,000 after acquiring an additional 15,212 shares in the last quarter. TD Waterhouse Canada Inc. boosted its position in Cardinal Health by 253.0% during the 4th quarter. TD Waterhouse Canada Inc. now owns 2,358 shares of the company's stock valued at $279,000 after acquiring an additional 1,690 shares in the last quarter. Stifel Financial Corp lifted its holdings in shares of Cardinal Health by 0.6% during the fourth quarter. Stifel Financial Corp now owns 157,562 shares of the company's stock valued at $18,635,000 after purchasing an additional 907 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Cardinal Health by 3.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,601,322 shares of the company's stock valued at $189,390,000 after purchasing an additional 55,781 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Down 2.3%

Shares of CAH opened at $148.0430 on Friday. The firm has a market cap of $35.35 billion, a PE ratio of 22.95, a P/E/G ratio of 1.28 and a beta of 0.67. The firm has a fifty day simple moving average of $159.02 and a two-hundred day simple moving average of $145.33. Cardinal Health, Inc. has a 1-year low of $106.54 and a 1-year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company's quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio is currently 31.63%.

Insider Activity

In other news, insider Michelle D. Greene sold 13,500 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider directly owned 14,976 shares in the company, valued at approximately $2,228,728.32. This represents a 47.41% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jessica L. Mayer sold 38,078 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 271,676 shares of company stock worth $40,489,525. 0.09% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CAH shares. Leerink Partners lowered their target price on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a report on Tuesday, August 12th. Wall Street Zen lowered shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Citigroup reiterated a "neutral" rating and set a $170.00 target price (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health has an average rating of "Moderate Buy" and an average price target of $163.20.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.